Mark Mossler - Feb 14, 2025 Form 4 Insider Report for C4 Therapeutics, Inc. (CCCC)

Role
Chief Accounting Officer
Signature
/s/ Shagha Russell, Attorney-in-Fact
Stock symbol
CCCC
Transactions as of
Feb 14, 2025
Transactions value $
-$5,043
Form type
4
Date filed
2/18/2025, 04:55 PM
Previous filing
Apr 10, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CCCC Common Stock Tax liability -$5.04K -1.59K -8.01% $3.18 18.2K Feb 14, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person.